Nyrada (ASX:NYR) OCF Yield %: -6.87 (As of Jul. 13, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ASX:NYR Nyrada Inc ASX:NYR
35 GF Score
Price A$0.41
! 1 Warning Sign
View Full Analysis

What is Nyrada OCF Yield %?

Nyrada ASX:NYR -4.65% 35 OCF Yield % is -6.87 as of Jul. 13, 2026. GuruFocus rates ASX:NYR with a GF Score™ of 35/100. The stock has 1 warning sign investors should review. Among 1,410 Biotechnology companies, Nyrada ranks better than 53.26% on this metric.

OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

As of today, Nyrada's Trailing 12-Month Cash Flow from Operations is A$-7.30 Mil, and Market Cap is A$101.31 Mil. Therefore, Nyrada's OCF Yield % for today is -6.87%.

The historical rank and industry rank for Nyrada's OCF Yield % or its related term are showing as below:

ASX:NYR' s OCF Yield % Range Over the Past 10 Years
Min: -6.87   Med: 0   Max: -6.87
Current: -6.87


During the past 7 years, the highest OCF Yield % of Nyrada was -6.87%. The lowest was -6.87%. And the median was %.

ASX:NYR's OCF Yield % is ranked better than
53.26% of 1410 companies
in the Biotechnology industry
Industry Median: -8.315 vs ASX:NYR: -6.87

Nyrada's OCF Margin % for the quarter that ended in Dec. 2025 was %.


Nyrada OCF Yield % Explanation

Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Nyrada OCF Yield % Related Terms


Nyrada OCF Yield % Historical Data

* Premium members only.

The historical data trend for Nyrada's OCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nyrada OCF Yield % Chart

Nyrada Annual Data
Trend Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
OCF Yield %
Get a 7-Day Free Trial -5.55 -13.88 -164.80 -7.13 -9.98

Nyrada Semi-Annual Data
Jun19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
OCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 54.54 -31.66 -22.48 -11.18 -3.28

ASX:NYR vs VRTX, REGN, ALNY: OCF Yield % Comparison

For the Biotechnology subindustry, Nyrada's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nyrada OCF Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Nyrada's OCF Yield % distribution charts can be found below:

* The bar in red indicates where Nyrada's OCF Yield % falls into.


ASX:NYR
35GF Score
Nyrada Inc ASX:NYR
OCF Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nyrada OCF Yield % Calculation

OCF Yield % is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

Nyrada's OCF Yield % for the fiscal year that ended in Jun. 2025 is calculated as

OCF Yield %=Cash Flow from Operations / Market Cap
=-5.052 / 50.62008
=-9.98%

Nyrada's annualized OCF Yield % for the quarter that ended in Dec. 2025 is calculated as

OCF Yield %=Cash Flow from Operations * Annualized Factor / Market Cap
=-4.468 * 2 / 272.45008
=-3.28%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Yield % →
What does a OCF Yield % of -6.87 mean?
Nyrada (ASX:NYR) has a OCF Yield % of -6.87 as of Jul. 13, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Nyrada and its competitors. According to the industry distribution chart, Nyrada ranks #659 out of 1410 companies in the Biotechnology industry, placing it in the top 46.7%.
Is Nyrada's OCF Yield % too high?
Nyrada's current OCF Yield % is -6.87. Based on the distribution chart, Nyrada ranks #659 out of 1410 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Nyrada has a GF Score™ of 35/100, reflecting its overall financial health beyond just this single metric.
How does Nyrada's OCF Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Nyrada ranks #659 out of 1410 companies for OCF Yield %. This puts Nyrada in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Biotechnology company?
A good OCF Yield % depends on the Biotechnology industry context. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Nyrada and its competitors. Nyrada's current OCF Yield % is -6.87. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nyrada stock overvalued right now?
Nyrada (ASX:NYR) has a current OCF Yield % of -6.87. The current OCF Yield % is -6.87. Nyrada's overall GF Score™ is 35/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Nyrada (ASX:NYR), the current OCF Yield % is -6.87 as of Jul. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Nyrada Business Description

Address 180 George Street, Sydney Place, Level 22/23, Salesforce Tower, Sydney, NSW, AUS, 2000
Nyrada Inc is a preclinical-stage, drug discovery, and development company, specializing in novel small-molecule drugs to treat cardiovascular and neurological diseases. It operates in one segment: research and development of drugs focusing on small molecules with potential therapeutic benefit in areas of medical needs. The company's two programs center on cholesterol-lowering and brain injury, each targeting market sectors of notable size and unmet clinical needs. The programs are focused on developing an oral, small molecule cholesterol-lowering drug, and a drug to treat secondary brain damage following a stroke or traumatic brain injury.
35GF Score

Get the complete analysis for ASX:NYR

OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$0.41
Price